BioCardia, Inc. (BCDA) vs Chemomab Therapeutics Ltd. Sponsored ADR (CMMB)
BioCardia, Inc. and Chemomab Therapeutics Ltd. Sponsored ADR are both Biotechnology companies. BioCardia, Inc. and Chemomab Therapeutics Ltd. Sponsored ADR are of similar size ($16.2M and $16.0M). Across the 10 metrics below, Chemomab Therapeutics Ltd. Sponsored ADR leads on 6 and BioCardia, Inc. on 4.
Valuation
Profitability
| Metric | BCDA | CMMB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (1,803.19%) | (82.17%) | (57.72%) |
| Return on assets | (214.47%) | (70.70%) | (49.22%) |
| Return on invested capital | 0.00% | (247.40%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack